High-risk medical devices that undergo post-approval modifications are more likely to be recalled from the U.S. market, according to an analysis published in JAMA Network Open.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,